Article: COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020).
Gastroenterologia y hepatologia
2020 Volume 43, Issue 7, Page(s) 408–413
Abstract: ... may modify the disease course of COVID-19. The Spanish Working Group on Crohn's Disease and ... Ulcerative Colitis and the Spanish Nurses Working Group on Inflammatory Bowel Disease have prepared this document ... in inflammatory bowel disease is of special interest, as these patients have higher attendance at health centres ...
| Title translation | COVID-19 y enfermedad inflamatoria intestinal: preguntas surgidas de la atención y seguimiento de los pacientes durante la fase inicial de la pandemia (febrero-abril 2020). |
|---|---|
| Abstract | COVID-19 is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was described in China in late 2019. There are currently more than three million diagnosed cases, constituting a pandemic which has caused a worldwide crisis. The devastating effects of this infection are due to its highly contagious nature and although mild forms predominate, in absolute values, the rates for severe forms and mortality are very high. The information on the characteristics of the infection in inflammatory bowel disease is of special interest, as these patients have higher attendance at health centres, which may increase their risk of infection. Furthermore, the treatments used to control the inflammatory activity may modify the disease course of COVID-19. The Spanish Working Group on Crohn's Disease and Ulcerative Colitis and the Spanish Nurses Working Group on Inflammatory Bowel Disease have prepared this document as a practical response to some common questions about the treatment of these patients. |
| MeSH term(s) | Anxiety/etiology ; Betacoronavirus ; Biological Products/adverse effects ; Biological Products/therapeutic use ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques ; Comorbidity ; Contraindications, Drug ; Coronavirus Infections/diagnosis ; Coronavirus Infections/drug therapy ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Coronavirus Infections/transmission ; Diarrhea/etiology ; Disease Susceptibility ; Drug Interactions ; Endoscopy, Gastrointestinal/adverse effects ; Family Characteristics ; Fear ; Humans ; Immunocompromised Host ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Inflammatory Bowel Diseases/complications ; Inflammatory Bowel Diseases/drug therapy ; Inflammatory Bowel Diseases/epidemiology ; Occupational Diseases/prevention & control ; Pandemics/prevention & control ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; Pneumonia, Viral/transmission ; Quarantine ; Risk ; SARS-CoV-2 ; Spain/epidemiology ; Vitamin B 12/administration & dosage ; Vitamin B 12 Deficiency/drug therapy ; Vitamin B 12 Deficiency/etiology ; Workplace ; COVID-19 Drug Treatment |
| Chemical Substances | Biological Products ; Immunosuppressive Agents ; Vitamin B 12 (P6YC3EG204) |
| Keywords | covid19 |
| Language | Spanish |
| Publishing date | 2020-05-15 |
| Publishing country | Spain |
| Document type | Practice Guideline |
| ZDB-ID | 632502-6 |
| ISSN | 0210-5705 |
| ISSN | 0210-5705 |
| DOI | 10.1016/j.gastrohep.2020.05.003 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2044: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.